IL-1β production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: Relevance to systemic vasculitis

Clinical and Experimental Immunology

Volumn 106, Issue 2, 1996, Pages 273-279

  Brooks, C J ^b   King, W J ^b   Radford, D J ^b   Adu, D ^b   McGrath, M ^b   Savage, C O S ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NONE

Author keywords

anti neutrophil cytoplasmic antibodies; IL 1; neutrophils

Indexed keywords

AUTOANTIBODY; CYCLOSPORIN A; ELASTASE; GRANULOCYTE ANTIBODY; IMMUNOGLOBULIN; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY; MYELOBLASTIN; TACROLIMUS;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPHIL; PRIORITY JOURNAL; SYSTEMIC VASCULITIS;

EID: 0029801153     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-835.x     Document Type: Article

References (29)

1. Cassatella MA, Bazzoni F, Ceska M, Ferro I, Baggiolini M, Berton G. IL-8 production by human polymorphonuclcur leukocytes: the chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin sensitive pathway. J Immunol 1992; 148:3216-20.
2. Cassatella MA, Meda L, Gasperini S, D'Andrea A, Ma X, Trinchieri G. Interleukin-12 production by human polymorphonuclear leukocytes. Eur J Immunol 1995; 25:1-5.
3. Xing Z, Kirpalani H, Torry D, Jordana M, Gauldie J. Polymorphonuclearleukocytes as a significant source of tumour necrosis factor-α in endotoxin-challenged lung tissue. Am J Pathol 1993; 143:1009-15.
4. Kuhns DB, Gallin JI. Increased cell-associated IL-8 in human exudative and A23187-treated peripheral blood neutrophils. J Immunol 1995; 154:6556-62.
5. Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995; 16:21-6.
6. Churg J, Churg A. Idiopathic and secondary vasculitis: a review. Modern Pathol 1989; 2:144-60.
7. Pall AA, Varagunam M, Adu D et al. Anti-idiotypic activity against MPO antibodies in pooled human immunoglobulin. Clin Exp Immunol 1994; 95:257-62.
8. Calafat J, Goldschmeding R, Ringeling PL, Janssen H, van der School CE. In situ localization by double-labeling immunoelectron microscopy of anti-neutrophil cytoplasmic autoantibodies in neutrophils and monocytes. Blood 1990; 75:242-50.
9. Csernok E, Ludemann J, Gross WL, Bainton DF. Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis. Am J Pathol 1990; 137:1113-20.
10. Mulder AHL, Heeringa C, Brouwer E, Limburg PC, Kallenberg CGM. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a FcγRII-dependent process. Clin Exp Immunol 1994; 98:270-8.
11. Savage COS, Pottinger BE, Gaskin G, Pusey CD, Pearson JD. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity towards cultured endothelial cells. Am J Pathol 1992; 141:335-42.
12. Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 1992; 41:375-83.
13. Jennette JC, Falk RJ. Andrassy K et al. Nomenclature of systemic vasculitides: the proposal of an International Consensus Conference. Arthritis Rheum 1994; 37:187-92.
14. Toothill VJ, Van-Mourik JA, Niewenhuis HK, Metzelaar MJ, Pearson JD. Characterization of the enhanced adhesion of neutrophil leukocytes to thrombin-stimulated endothelial cells. J Immunol 1990; 145:283-91.
15. Jepsen JL, Skottum T. A rapid one-step method for the isolation of human granulocytes from whole blood. Scand J Clin Invest 1982; 42:235-8.
16. Wiik A, Rasmussen N, Wieslander J. Methods to detect autoantibodies to neutrophilic granulocytes. Manual of biological markers of disease. Amsterdam: Kluwer Academic, 1993:1-14.
17. Ehlers S, Smith K. Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J Exp Med 1991; 173:25-36.
18. King WJ, Adu D, Daha MR et al. Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen proteinase 3. Clin Exp Immunol 1995; 102:98-105.
19. Marucha PT, Zeff RA, Kreutzer DL. Cytokine regulation of IL-1β gene expression in the human polymorphonuclear leukocyte. J Immunol 1990; 145:2932-7.
20. Moore NC, Anderson G, Smith CA, Owen JJT, Jenkinson EJ. Analysis of cytokine gene expression in subpopulations of freshly isolated thymocytes and thymic stromal cells using semiquantitative polymerase chain reaction. Eur J Immunol 1993; 23:922-6.
21. Jayne DRW, Davies MJ, Fox CJV, Black CM, Lockwood CM. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 1990; 337:1137-9.
22. Porges AJ, Redecha PB, Kimberly WT, Csernok E, Gross W, Kimberly RP. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via FcγIIa. J Immunol 1994; 153: 1271-80.
23. Lindemann A, Riedel D, Oster W et al. Granulocyte macrophage colony-stimulating factor induces interleukin 1 production by human polymorphonuclear neutrophils. J Immunol 1988; 140: 837-9.
24. Goldschmeding R, van der Schoot CE, ten Bokkel Huinink D et al. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorphosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 1989; 84:1577-87.
25. Dentener MA, Smit FT, Francot GJM, Buurman WA. Characterization of two monoclonal antibodies directed against bactericidal permeability-increasing protein. J Immunol Dis 1994; 170:1483-9.
26. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87:4115-9.
27. Keogan MT, Esnault VLM, Green AJ, Lockwood CM, Brown DL. Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies. Clin Exp Immunol 1992; 90:228-34.
28. Rossi F, Jayne DRW, Lockwood CM, Kazatchkine MD. Antiidiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera in patients with systemic vasculitis. Clin Exp Immunol 1991; 83:298-303.
29. Burnett D, Adams DH, Martin TMJ et al. Inhibition by FK506 of formyl peptide-induced neutrophil activation and associated protein synthesis. Biochem Pharmacol 1994; 48:1081-8.